| Title : Preclinical and first-in-human evaluation of PRX-105, a PEGylated, plant-derived, recombinant human acetylcholinesterase-R - Atsmon_2015_Toxicol.Appl.Pharmacol_287_202 |
| Author(s) : Atsmon J , Brill-Almon E , Nadri-Shay C , Chertkoff R , Alon S , Shaikevich D , Volokhov I , Haim KY , Bartfeld D , Shulman A , Ruderfer I , Ben-Moshe T , Shilovitzky O , Soreq H , Shaaltiel Y |
| Ref : Toxicol Appl Pharmacol , 287 :202 , 2015 |
| Abstract : Atsmon_2015_Toxicol.Appl.Pharmacol_287_202 |
| ESTHER : Atsmon_2015_Toxicol.Appl.Pharmacol_287_202 |
| PubMedSearch : Atsmon_2015_Toxicol.Appl.Pharmacol_287_202 |
| PubMedID: 26051873 |
Atsmon J, Brill-Almon E, Nadri-Shay C, Chertkoff R, Alon S, Shaikevich D, Volokhov I, Haim KY, Bartfeld D, Shulman A, Ruderfer I, Ben-Moshe T, Shilovitzky O, Soreq H, Shaaltiel Y (2015)
Preclinical and first-in-human evaluation of PRX-105, a PEGylated, plant-derived, recombinant human acetylcholinesterase-R
Toxicol Appl Pharmacol
287 :202
Atsmon J, Brill-Almon E, Nadri-Shay C, Chertkoff R, Alon S, Shaikevich D, Volokhov I, Haim KY, Bartfeld D, Shulman A, Ruderfer I, Ben-Moshe T, Shilovitzky O, Soreq H, Shaaltiel Y (2015)
Toxicol Appl Pharmacol
287 :202